Welkom bij Campus Sanofi Nederland
- Artikel
- Campus Sanofi
- 19 mrt 2024
Een platform voor beroepsbeoefenaren om betrouwbare en relevante informatie over onze medicijnen en therapieën te vinden.
InloggenWetenschappelijk nieuws
Living with ITP
Patients reported significant quality of life (QoL) challenges related to their ITP1
Bekijk meer
What is Immune Thrombocytopenia (ITP)?
Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).1-5
Bekijk meer
Mechanism of Disease
Complex immune dysregulation can lead to autoimmunity and inflammation1-6
Bekijk meer